Literature DB >> 778329

Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections.

A K Ng, C L Chen, C M Chang, A Nowotny.   

Abstract

Rabbit antisera were prepared against the heptoseless Re mutants, Salmonella minnesota R595 and S. typhimurium SLI102, as well as against purified R595 glycolipid coated on autologous erythrocytes. The antisera cross-reacted with the endotoxic glycolipids extracted from Re mutants of various bacterial strains, including S. minnesota R595, S. typhimurium SLI102, Escherichia coli D3Im4, E. coli D2If2 and E. coli F515, as shown by passive haemagglutination and gel diffusion tests. The anti-Re sera also cross-reacted with the RESI preparations (a purified 'lipid A' fraction) from the endotoxic lipopolysaccharides of various heterologous smooth Gram-negative bacteria including Serratia marcescens. Psuedomonas fluorescens and E. coli 0127. However, the same antisera failed to protect mice against infection by Gram-negative bacteria such as Klebsiella pneumoniae type II, S. typhi 0901, P. aeruginosa 119 and E. coli. The results suggest that although the lipid moieties of the lipopolysaccharides in the cell wall of Gram-negative bacteria share cross-reactive immunodeterminant groups, these groups may not be accessible to antibody against them.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 778329     DOI: 10.1099/00221287-94-1-107

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  19 in total

Review 1.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

Review 2.  Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.

Authors:  D L Dunn
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

3.  Protection of mice against the lethal toxicity of a lipopolysaccharide (LPS) by immunization with anti-idiotype antibody to a monoclonal antibody to lipid A from Eikenella corrodens LPS.

Authors:  T Kato; I Takazoe; K Okuda
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Common lipopolysaccharide specificity: new type of antigen residing in the inner core region of S- and R-form lipopolysaccharides from different families of gram-negative bacteria.

Authors:  H Brade; C Galanos
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

5.  Serological diagnosis of typhoid fever by counterimmunoelectrophoresis.

Authors:  R S Tsang; P Y Chau
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-09

Review 6.  Immunological aspects to severe bacterial sepsis.

Authors:  N Clumeck; C George
Journal:  Intensive Care Med       Date:  1981-04       Impact factor: 17.440

7.  Lipid A and anti-lipid A.

Authors:  I Mattsby-Baltzer; B Kaijser
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Role of bacterial products in periodontitis: immune response in gnotobiotic rats monoinfected with Eikenella corrodens.

Authors:  D A Johnson; U H Behling; C H Lai; M Listgarten; S Socransky; A Nowotny
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

9.  Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.

Authors:  W C Bogard; D L Dunn; K Abernethy; C Kilgarriff; P C Kung
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

10.  Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region.

Authors:  B J Appelmelk; A M Verwey-van Vught; J J Maaskant; W F Schouten; L G Thijs; D M Maclaren
Journal:  Antonie Van Leeuwenhoek       Date:  1986       Impact factor: 2.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.